Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023

Upgrades

For Algonquin Power & Utilities Corp AQN, Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Algonquin Power showed an EPS of $0.11, compared to $0.15 from the year-ago quarter. The current stock performance of Algonquin Power shows a 52-week-high of $16.01 and a 52-week-low of $6.41. Moreover, at the end of the last trading period, the closing price was at $6.86.

For FirstCash Holdings Inc FCFS, Stephens & Co. upgraded the previous rating of Equal-Weight to Overweight. FirstCash Hldgs earned $1.30 in the third quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $100.00 and a 52-week-low of $58.30. At the end of the last trading period, FirstCash Hldgs closed at $86.70.

Truist Securities upgraded the previous rating for Charter Communications Inc CHTR from Hold to Buy. Charter Communications earned $7.38 in the third quarter, compared to $6.50 in the year-ago quarter. The stock has a 52-week-high of $653.09 and a 52-week-low of $297.66. At the end of the last trading period, Charter Communications closed at $354.00.

Jefferies upgraded the previous rating for Check Point Software Technologies Ltd CHKP from Hold to Buy. Check Point Software earned $1.77 in the third quarter, compared to $1.65 in the year-ago quarter. The current stock performance of Check Point Software shows a 52-week-high of $149.62 and a 52-week-low of $107.54. Moreover, at the end of the last trading period, the closing price was at $127.20.

For DocuSign Inc DOCU, Jefferies upgraded the previous rating of Hold to Buy. DocuSign earned $0.57 in the third quarter, compared to $0.58 in the year-ago quarter. The current stock performance of DocuSign shows a 52-week-high of $156.41 and a 52-week-low of $39.57. Moreover, at the end of the last trading period, the closing price was at $56.27.

According to Jefferies, the prior rating for Atlassian Corp TEAM was changed from Hold to Buy. Atlassian earned $0.36 in the first quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $352.92 and a 52-week-low of $113.86. At the end of the last trading period, Atlassian closed at $126.40.

For Oracle Corp ORCL, Jefferies upgraded the previous rating of Hold to Buy. For the second quarter, Oracle had an EPS of $1.21, compared to year-ago quarter EPS of $1.21. The current stock performance of Oracle shows a 52-week-high of $89.58 and a 52-week-low of $60.78. Moreover, at the end of the last trading period, the closing price was at $84.48.

According to Argus Research, the prior rating for Delta Air Lines Inc DAL was changed from Hold to Buy. Delta Air Lines earned $1.51 in the third quarter, compared to $0.30 in the year-ago quarter. The current stock performance of Delta Air Lines shows a 52-week-high of $46.27 and a 52-week-low of $27.20. Moreover, at the end of the last trading period, the closing price was at $34.39.

For Olin Corp OLN, Barclays upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Olin showed an EPS of $2.18, compared to $2.38 from the year-ago quarter. The stock has a 52-week-high of $67.25 and a 52-week-low of $41.33. At the end of the last trading period, Olin closed at $53.29.

Raymond James upgraded the previous rating for Zimmer Biomet Holdings Inc ZBH from Market Perform to Outperform. In the third quarter, Zimmer Biomet Holdings showed an EPS of $1.58, compared to $1.81 from the year-ago quarter. At the moment, the stock has a 52-week-high of $135.05 and a 52-week-low of $100.39. Zimmer Biomet Holdings closed at $128.46 at the end of the last trading period.

Truist Securities upgraded the previous rating for Silgan Holdings Inc SLGN from Hold to Buy. In the third quarter, Silgan Hldgs showed an EPS of $1.27, compared to $1.02 from the year-ago quarter. The stock has a 52-week-high of $54.59 and a 52-week-low of $38.59. At the end of the last trading period, Silgan Hldgs closed at $51.58.

Truist Securities upgraded the previous rating for Comcast Corp CMCSA from Hold to Buy. Comcast earned $0.96 in the third quarter, compared to $0.87 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.10 and a 52-week-low of $28.39. Comcast closed at $36.59 at the end of the last trading period.

Stephens & Co. upgraded the previous rating for Bread Financial Holdings Inc BFH from Equal-Weight to Overweight. In the third quarter, Bread Financial Holdings showed an EPS of $2.69, compared to $4.47 from the year-ago quarter. At the moment, the stock has a 52-week-high of $60.79 and a 52-week-low of $28.85. Bread Financial Holdings closed at $40.11 at the end of the last trading period.

Barclays upgraded the previous rating for US Foods Holding Corp USFD from Equal-Weight to Overweight. For the third quarter, US Foods Hldg had an EPS of $0.60, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $39.73 and a 52-week-low of $25.49. At the end of the last trading period, US Foods Hldg closed at $34.78.

Goldman Sachs upgraded the previous rating for First Republic Bank FRC from Neutral to Buy. For the third quarter, First Republic Bank had an EPS of $2.21, compared to year-ago quarter EPS of $1.91. The current stock performance of First Republic Bank shows a 52-week-high of $209.30 and a 52-week-low of $106.86. Moreover, at the end of the last trading period, the closing price was at $123.79.

B of A Securities upgraded the previous rating for Cullen/Frost Bankers Inc CFR from Neutral to Buy. Cullen/Frost Bankers earned $2.59 in the third quarter, compared to $1.65 in the year-ago quarter. At the moment, the stock has a 52-week-high of $160.60 and a 52-week-low of $112.67. Cullen/Frost Bankers closed at $131.03 at the end of the last trading period.

According to B of A Securities, the prior rating for FibroGen Inc FGEN was changed from Neutral to Buy. FibroGen earned $0.98 in the third quarter, compared to $0.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $18.31 and a 52-week-low of $7.81. FibroGen closed at $16.10 at the end of the last trading period.

For Reinsurance Group of America Inc RGA, Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the third quarter, Reinsurance Group had an EPS of $5.20, compared to year-ago quarter EPS of $1.11. The current stock performance of Reinsurance Group shows a 52-week-high of $148.75 and a 52-week-low of $97.61. Moreover, at the end of the last trading period, the closing price was at $142.03.

According to B of A Securities, the prior rating for The Interpublic Group of Companies Inc IPG was changed from Underperform to Neutral. For the third quarter, Interpublic Gr of Cos had an EPS of $0.63, compared to year-ago quarter EPS of $0.60. At the moment, the stock has a 52-week-high of $39.98 and a 52-week-low of $25.14. Interpublic Gr of Cos closed at $34.70 at the end of the last trading period.

Credit Suisse upgraded the previous rating for CME Group Inc CME from Neutral to Outperform. CME Group earned $1.98 in the third quarter, compared to $1.60 in the year-ago quarter. The stock has a 52-week-high of $256.94 and a 52-week-low of $166.54. At the end of the last trading period, CME Group closed at $170.08.

For Cboe Global Markets Inc CBOE, Credit Suisse upgraded the previous rating of Neutral to Outperform. For the third quarter, Cboe Global Markets had an EPS of $1.74, compared to year-ago quarter EPS of $1.45. At the moment, the stock has a 52-week-high of $130.54 and a 52-week-low of $103.82. Cboe Global Markets closed at $124.47 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

Seaport Global downgraded the previous rating for American States Water Co AWR from Buy to Neutral. American States Water earned $0.69 in the third quarter, compared to $0.76 in the year-ago quarter. The stock has a 52-week-high of $102.89 and a 52-week-low of $71.22. At the end of the last trading period, American States Water closed at $96.25.

For SJW Group SJW, Seaport Global downgraded the previous rating of Buy to Neutral. In the third quarter, SJW Gr showed an EPS of $0.82, compared to $0.64 from the year-ago quarter. The current stock performance of SJW Gr shows a 52-week-high of $83.88 and a 52-week-low of $55.73. Moreover, at the end of the last trading period, the closing price was at $83.35.

Jefferies downgraded the previous rating for Palantir Technologies Inc PLTR from Buy to Hold. For the third quarter, Palantir Technologies had an EPS of $0.01, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $18.84 and a 52-week-low of $5.92. At the end of the last trading period, Palantir Technologies closed at $6.58.

According to Loop Capital, the prior rating for Armstrong World Industries Inc AWI was changed from Buy to Hold. In the third quarter, Armstrong World Indus showed an EPS of $1.36, compared to $1.17 from the year-ago quarter. The current stock performance of Armstrong World Indus shows a 52-week-high of $117.64 and a 52-week-low of $66.86. Moreover, at the end of the last trading period, the closing price was at $70.40.

For Dropbox Inc DBX, Jefferies downgraded the previous rating of Buy to Hold. For the third quarter, Dropbox had an EPS of $0.43, compared to year-ago quarter EPS of $0.37. The current stock performance of Dropbox shows a 52-week-high of $25.80 and a 52-week-low of $19.07. Moreover, at the end of the last trading period, the closing price was at $22.81.

Jefferies downgraded the previous rating for Vertex Inc VERX from Buy to Hold. In the third quarter, Vertex showed an EPS of $0.08, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $19.30 and a 52-week-low of $9.44. Vertex closed at $14.76 at the end of the last trading period.

For Verint Systems Inc VRNT, Jefferies downgraded the previous rating of Buy to Hold. Verint Systems earned $0.69 in the third quarter, compared to $0.69 in the year-ago quarter. The stock has a 52-week-high of $56.39 and a 52-week-low of $31.63. At the end of the last trading period, Verint Systems closed at $37.08.

Jefferies downgraded the previous rating for Varonis Systems Inc VRNS from Buy to Hold. For the third quarter, Varonis Systems had an EPS of $0.05, compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of $51.60 and a 52-week-low of $15.61. Varonis Systems closed at $24.45 at the end of the last trading period.

According to Jefferies, the prior rating for Five9 Inc FIVN was changed from Buy to Hold. Five9 earned $0.39 in the third quarter, compared to $0.28 in the year-ago quarter. The current stock performance of Five9 shows a 52-week-high of $144.24 and a 52-week-low of $46.61. Moreover, at the end of the last trading period, the closing price was at $69.24.

For CrowdStrike Holdings Inc CRWD, Jefferies downgraded the previous rating of Buy to Hold. CrowdStrike Holdings earned $0.40 in the third quarter, compared to $0.17 in the year-ago quarter. The current stock performance of CrowdStrike Holdings shows a 52-week-high of $242.00 and a 52-week-low of $98.70. Moreover, at the end of the last trading period, the closing price was at $104.36.

For Shopify Inc SHOP, Jefferies downgraded the previous rating of Buy to Hold. For the third quarter, Shopify had an EPS of $0.02, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $1370.00 and a 52-week-low of $23.63. Shopify closed at $37.54 at the end of the last trading period.

UBS downgraded the previous rating for Gap Inc GPS from Neutral to Sell. In the third quarter, Gap showed an EPS of $0.71, compared to $0.27 from the year-ago quarter. The stock has a 52-week-high of $19.06 and a 52-week-low of $7.79. At the end of the last trading period, Gap closed at $11.78.

For Ally Financial Inc ALLY, B of A Securities downgraded the previous rating of Buy to Underperform. For the third quarter, Ally Financial had an EPS of $1.12, compared to year-ago quarter EPS of $2.16. The current stock performance of Ally Financial shows a 52-week-high of $53.83 and a 52-week-low of $22.34. Moreover, at the end of the last trading period, the closing price was at $25.24.

According to Argus Research, the prior rating for CarMax Inc KMX was changed from Buy to Hold. For the third quarter, CarMax had an EPS of $0.24, compared to year-ago quarter EPS of $1.53. The stock has a 52-week-high of $129.05 and a 52-week-low of $52.10. At the end of the last trading period, CarMax closed at $65.12.

According to UBS, the prior rating for Victoria's Secret & Co VSCO was changed from Neutral to Sell. In the third quarter, Victoria's Secret showed an EPS of $0.29, compared to $0.81 from the year-ago quarter. The current stock performance of Victoria's Secret shows a 52-week-high of $65.20 and a 52-week-low of $26.14. Moreover, at the end of the last trading period, the closing price was at $34.21.

According to Wells Fargo, the prior rating for Delek US Holdings Inc DK was changed from Overweight to Underweight. In the third quarter, Delek US Hldgs showed an EPS of $0.02, compared to $0.13 from the year-ago quarter. The current stock performance of Delek US Hldgs shows a 52-week-high of $35.45 and a 52-week-low of $14.71. Moreover, at the end of the last trading period, the closing price was at $25.64.

For The Wendy's Co WEN, Oppenheimer downgraded the previous rating of Outperform to Perform. Wendy's earned $0.24 in the third quarter, compared to $0.19 in the year-ago quarter. The current stock performance of Wendy's shows a 52-week-high of $24.48 and a 52-week-low of $15.77. Moreover, at the end of the last trading period, the closing price was at $22.82.

For Progyny Inc PGNY, SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the third quarter, Progyny showed an EPS of $0.13, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $53.10 and a 52-week-low of $25.67. Progyny closed at $31.13 at the end of the last trading period.

For Qualys Inc QLYS, Needham downgraded the previous rating of Buy to Hold. For the third quarter, Qualys had an EPS of $0.94, compared to year-ago quarter EPS of $0.86. At the moment, the stock has a 52-week-high of $162.36 and a 52-week-low of $107.69. Qualys closed at $112.09 at the end of the last trading period.

According to Raymond James, the prior rating for Veritex Holdings Inc VBTX was changed from Outperform to Market Perform. In the third quarter, Veritex Holdings showed an EPS of $0.80, compared to $0.70 from the year-ago quarter. The current stock performance of Veritex Holdings shows a 52-week-high of $43.33 and a 52-week-low of $26.14. Moreover, at the end of the last trading period, the closing price was at $28.08.

Raymond James downgraded the previous rating for CrossFirst Bankshares Inc CFB from Outperform to Market Perform. For the third quarter, CrossFirst Bankshares had an EPS of $0.35, compared to year-ago quarter EPS of $0.41. The current stock performance of CrossFirst Bankshares shows a 52-week-high of $16.50 and a 52-week-low of $12.17. Moreover, at the end of the last trading period, the closing price was at $12.43.

Raymond James downgraded the previous rating for Business First Bancshares Inc BFST from Outperform to Market Perform. Business First Bancshares earned $0.72 in the third quarter, compared to $0.53 in the year-ago quarter. The current stock performance of Business First Bancshares shows a 52-week-high of $29.50 and a 52-week-low of $20.19. Moreover, at the end of the last trading period, the closing price was at $21.83.

According to Raymond James, the prior rating for Baxter International Inc BAX was changed from Outperform to Market Perform. In the third quarter, Baxter Intl showed an EPS of $0.82, compared to $1.02 from the year-ago quarter. The stock has a 52-week-high of $89.70 and a 52-week-low of $49.00. At the end of the last trading period, Baxter Intl closed at $52.33.

For Berry Global Group Inc BERY, Truist Securities downgraded the previous rating of Buy to Hold. In the fourth quarter, Berry Global Gr showed an EPS of $2.19, compared to $1.55 from the year-ago quarter. The stock has a 52-week-high of $74.73 and a 52-week-low of $44.52. At the end of the last trading period, Berry Global Gr closed at $61.52.

Stephens & Co. downgraded the previous rating for American Express Co AXP from Equal-Weight to Underweight. For the third quarter, American Express had an EPS of $2.47, compared to year-ago quarter EPS of $2.27. The stock has a 52-week-high of $199.55 and a 52-week-low of $130.65. At the end of the last trading period, American Express closed at $150.54.

Truist Securities downgraded the previous rating for Sealed Air Corp SEE from Buy to Hold. Sealed Air earned $0.98 in the third quarter, compared to $0.86 in the year-ago quarter. The current stock performance of Sealed Air shows a 52-week-high of $70.72 and a 52-week-low of $41.24. Moreover, at the end of the last trading period, the closing price was at $51.07.

According to Piper Sandler, the prior rating for Revolve Group Inc RVLV was changed from Overweight to Neutral. In the third quarter, Revolve Gr showed an EPS of $0.16, compared to $0.22 from the year-ago quarter. The current stock performance of Revolve Gr shows a 52-week-high of $63.92 and a 52-week-low of $20.17. Moreover, at the end of the last trading period, the closing price was at $23.41.

For Nordstrom Inc JWN, Piper Sandler downgraded the previous rating of Overweight to Neutral. Nordstrom earned $0.20 in the third quarter, compared to $0.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $29.59 and a 52-week-low of $15.53. Nordstrom closed at $16.62 at the end of the last trading period.

Stephens & Co. downgraded the previous rating for Capital One Financial Corp COF from Equal-Weight to Underweight. Capital One Financial earned $4.20 in the third quarter, compared to $6.86 in the year-ago quarter. The stock has a 52-week-high of $162.40 and a 52-week-low of $86.98. At the end of the last trading period, Capital One Financial closed at $95.80.

Piper Sandler downgraded the previous rating for Allbirds Inc BIRD from Overweight to Neutral. In the third quarter, Allbirds showed an EPS of $0.15, compared to $0.25 from the year-ago quarter. The current stock performance of Allbirds shows a 52-week-high of $16.78 and a 52-week-low of $2.14. Moreover, at the end of the last trading period, the closing price was at $2.42.

According to Goldman Sachs, the prior rating for Essent Group Ltd ESNT was changed from Buy to Neutral. For the third quarter, Essent Gr had an EPS of $1.66, compared to year-ago quarter EPS of $1.84. The stock has a 52-week-high of $50.17 and a 52-week-low of $34.27. At the end of the last trading period, Essent Gr closed at $39.51.

For Dorian LPG Ltd LPG, UBS downgraded the previous rating of Buy to Neutral. In the second quarter, Dorian LPG showed an EPS of $0.43, compared to $0.25 from the year-ago quarter. The current stock performance of Dorian LPG shows a 52-week-high of $21.07 and a 52-week-low of $10.77. Moreover, at the end of the last trading period, the closing price was at $17.46.

For Y-mAbs Therapeutics Inc YMAB, Cowen & Co. downgraded the previous rating of Outperform to Market Perform. Y-mAbs Therapeutics earned $0.63 in the third quarter, compared to $0.66 in the year-ago quarter. At the moment, the stock has a 52-week-high of $20.48 and a 52-week-low of $2.94. Y-mAbs Therapeutics closed at $5.11 at the end of the last trading period.

Cowen & Co. downgraded the previous rating for C.H. Robinson Worldwide Inc CHRW from Outperform to Market Perform. For the third quarter, C.H. Robinson Worldwide had an EPS of $1.78, compared to year-ago quarter EPS of $1.85. The stock has a 52-week-high of $121.23 and a 52-week-low of $86.57. At the end of the last trading period, C.H. Robinson Worldwide closed at $90.80.

Cowen & Co. downgraded the previous rating for Coinbase Global Inc COIN from Outperform to Market Perform. Coinbase Global earned $2.43 in the third quarter, compared to $1.62 in the year-ago quarter. At the moment, the stock has a 52-week-high of $258.81 and a 52-week-low of $31.83. Coinbase Global closed at $37.70 at the end of the last trading period.

UBS downgraded the previous rating for Maravai LifeSciences Holdings Inc MRVI from Buy to Neutral. For the third quarter, Maravai LifeSciences had an EPS of $0.37, compared to year-ago quarter EPS of $0.44. At the moment, the stock has a 52-week-high of $41.82 and a 52-week-low of $12.16. Maravai LifeSciences closed at $13.98 at the end of the last trading period.

According to B of A Securities, the prior rating for Applied Molecular Transport Inc AMTI was changed from Buy to Underperform. Applied Molecular earned $0.65 in the third quarter, compared to $0.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.94 and a 52-week-low of $0.33. Applied Molecular closed at $0.48 at the end of the last trading period.

For EPAM Systems Inc EPAM, Wolfe Research downgraded the previous rating of Outperform to Peer Perform. In the third quarter, EPAM Sys showed an EPS of $3.10, compared to $2.42 from the year-ago quarter. At the moment, the stock has a 52-week-high of $646.16 and a 52-week-low of $168.59. EPAM Sys closed at $335.22 at the end of the last trading period.

B of A Securities downgraded the previous rating for PNC Financial Services Group Inc PNC from Neutral to Underperform. PNC Financial Services Gr earned $3.78 in the third quarter, compared to $3.75 in the year-ago quarter. The current stock performance of PNC Financial Services Gr shows a 52-week-high of $228.14 and a 52-week-low of $143.52. Moreover, at the end of the last trading period, the closing price was at $163.73.

For Cognizant Technology Solutions Corp CTSH, Wolfe Research downgraded the previous rating of Peer Perform to Underperform. For the third quarter, Cognizant Tech Solns had an EPS of $1.17, compared to year-ago quarter EPS of $1.06. At the moment, the stock has a 52-week-high of $93.47 and a 52-week-low of $51.33. Cognizant Tech Solns closed at $58.06 at the end of the last trading period.

For Nomad Foods Ltd NOMD, Credit Suisse downgraded the previous rating of Outperform to Neutral. In the third quarter, Nomad Foods showed an EPS of $0.52, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $26.89 and a 52-week-low of $12.50. Nomad Foods closed at $17.94 at the end of the last trading period.

For Danaher Corp DHR, Credit Suisse downgraded the previous rating of Outperform to Neutral. Danaher earned $2.56 in the third quarter, compared to $2.39 in the year-ago quarter. The stock has a 52-week-high of $316.04 and a 52-week-low of $233.71. At the end of the last trading period, Danaher closed at $266.37.

Baird downgraded the previous rating for IAA Inc IAA from Outperform to Neutral. In the third quarter, IAA showed an EPS of $0.45, compared to $0.52 from the year-ago quarter. At the moment, the stock has a 52-week-high of $51.12 and a 52-week-low of $31.32. IAA closed at $40.01 at the end of the last trading period.

Wolfe Research downgraded the previous rating for Cano Health Inc CANO from Outperform to Peer Perform. For the third quarter, Cano Health had an EPS of $0.23, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $9.75 and a 52-week-low of $0.98. Cano Health closed at $1.16 at the end of the last trading period.

For The AZEK Co Inc AZEK, UBS downgraded the previous rating of Buy to Neutral. In the fourth quarter, AZEK Co showed an EPS of $0.16, compared to $0.32 from the year-ago quarter. At the moment, the stock has a 52-week-high of $46.56 and a 52-week-low of $15.12. AZEK Co closed at $22.48 at the end of the last trading period.

Piper Sandler downgraded the previous rating for Wolverine World Wide Inc WWW from Overweight to Neutral. For the third quarter, Wolverine World Wide had an EPS of $0.48, compared to year-ago quarter EPS of $0.62. The stock has a 52-week-high of $29.30 and a 52-week-low of $9.60. At the end of the last trading period, Wolverine World Wide closed at $11.56.

See all analyst ratings downgrades.

Initiations

With a Hold rating, Craig-Hallum initiated coverage on Tempo Automation Holdings Inc TMPO. The price target seems to have been set at $1.00 for Tempo Automation Holdings. The stock has a 52-week-high of $15.15 and a 52-week-low of $0.70. At the end of the last trading period, Tempo Automation Holdings closed at $0.78.

Canaccord Genuity initiated coverage on R1 RCM Inc RCM with a Buy rating. The price target for R1 RCM is set to $14.00. In the third quarter, R1 RCM showed an EPS of $0.07, compared to $0.05 from the year-ago quarter. The current stock performance of R1 RCM shows a 52-week-high of $27.86 and a 52-week-low of $6.71. Moreover, at the end of the last trading period, the closing price was at $11.03.

Wolfe Research initiated coverage on Etsy Inc ETSY with a Peer Perform rating. In the third quarter, Etsy showed an EPS of $0.58, compared to $0.62 from the year-ago quarter. The current stock performance of Etsy shows a 52-week-high of $207.39 and a 52-week-low of $67.01. Moreover, at the end of the last trading period, the closing price was at $117.11.

With a Buy rating, B of A Securities initiated coverage on Amylyx Pharmaceuticals Inc AMLX. The price target seems to have been set at $50.00 for Amylyx Pharma. At the moment, the stock has a 52-week-high of $39.77 and a 52-week-low of $6.51. Amylyx Pharma closed at $35.54 at the end of the last trading period.

Wolfe Research initiated coverage on Squarespace Inc SQSP with a Peer Perform rating. For the third quarter, Squarespace had an EPS of $0.07, compared to year-ago quarter EPS of $0.02. At the moment, the stock has a 52-week-high of $34.97 and a 52-week-low of $14.43. Squarespace closed at $21.48 at the end of the last trading period.

Benchmark initiated coverage on Bragg Gaming Group Inc BRAG with a Speculative Buy rating. The price target for Bragg Gaming Group is set to $8.00. Bragg Gaming Group earned $0.09 in the third quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Bragg Gaming Group shows a 52-week-high of $7.98 and a 52-week-low of $2.30. Moreover, at the end of the last trading period, the closing price was at $4.08.

BMO Capital initiated coverage on AstraZeneca PLC AZN with an Outperform rating. The price target for AstraZeneca is set to $82.00. For the third quarter, AstraZeneca had an EPS of $0.84, compared to year-ago quarter EPS of $1.07. The stock has a 52-week-high of $71.70 and a 52-week-low of $52.65. At the end of the last trading period, AstraZeneca closed at $69.50.

With an Outperform rating, BMO Capital initiated coverage on Foghorn Therapeutics Inc FHTX. The price target seems to have been set at $20.00 for Foghorn Therapeutics. In the third quarter, Foghorn Therapeutics showed an EPS of $0.62, compared to $0.71 from the year-ago quarter. At the moment, the stock has a 52-week-high of $22.73 and a 52-week-low of $5.32. Foghorn Therapeutics closed at $6.53 at the end of the last trading period.

B. Riley Securities initiated coverage on Reservoir Media Inc RSVR with a Buy rating. The price target for Reservoir Media is set to $11.00. Reservoir Media earned $0.07 in the second quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $10.84 and a 52-week-low of $4.42. Reservoir Media closed at $6.05 at the end of the last trading period.

With a Neutral rating, Piper Sandler initiated coverage on Axsome Therapeutics Inc AXSM. The price target seems to have been set at $75.00 for Axsome Therapeutics. For the third quarter, Axsome Therapeutics had an EPS of $1.07, compared to year-ago quarter EPS of $0.93. The stock has a 52-week-high of $82.00 and a 52-week-low of $20.63. At the end of the last trading period, Axsome Therapeutics closed at $73.34.

With an Overweight rating, Piper Sandler initiated coverage on Karuna Therapeutics Inc KRTX. The price target seems to have been set at $285.00 for Karuna Therapeutics. For the third quarter, Karuna Therapeutics had an EPS of $2.38, compared to year-ago quarter EPS of $1.72. At the moment, the stock has a 52-week-high of $278.25 and a 52-week-low of $92.26. Karuna Therapeutics closed at $198.46 at the end of the last trading period.

Scotiabank initiated coverage on Guardant Health Inc GH with a Sector Outperform rating. The price target for Guardant Health is set to $36.00. In the third quarter, Guardant Health showed an EPS of $1.18, compared to $0.70 from the year-ago quarter. The current stock performance of Guardant Health shows a 52-week-high of $102.85 and a 52-week-low of $24.63. Moreover, at the end of the last trading period, the closing price was at $26.70.

Scotiabank initiated coverage on Illumina Inc ILMN with a Sector Perform rating. The price target for Illumina is set to $216.00. In the third quarter, Illumina showed an EPS of $0.34, compared to $1.45 from the year-ago quarter. The current stock performance of Illumina shows a 52-week-high of $428.00 and a 52-week-low of $173.45. Moreover, at the end of the last trading period, the closing price was at $202.61.

With a Sector Outperform rating, Scotiabank initiated coverage on Veracyte Inc VCYT. The price target seems to have been set at $33.00 for Veracyte. In the third quarter, Veracyte showed an EPS of $0.12, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $42.43 and a 52-week-low of $14.85. Veracyte closed at $23.77 at the end of the last trading period.

With a Sector Outperform rating, Scotiabank initiated coverage on Twist Bioscience Corp TWST. The price target seems to have been set at $33.00 for Twist Bioscience. Twist Bioscience earned $0.99 in the fourth quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $84.63 and a 52-week-low of $21.78. At the end of the last trading period, Twist Bioscience closed at $25.41.

Scotiabank initiated coverage on Adaptive Biotechnologies Corp ADPT with a Sector Outperform rating. The price target for Adaptive Biotechnologies is set to $15.00. In the third quarter, Adaptive Biotechnologies showed an EPS of $0.32, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $28.72 and a 52-week-low of $5.96. Adaptive Biotechnologies closed at $8.01 at the end of the last trading period.

With a Sector Outperform rating, Scotiabank initiated coverage on Bionano Genomics Inc BNGO. The price target seems to have been set at $4.00 for Bionano Genomics. In the third quarter, Bionano Genomics showed an EPS of $0.11, compared to $0.07 from the year-ago quarter. The current stock performance of Bionano Genomics shows a 52-week-high of $4.35 and a 52-week-low of $1.16. Moreover, at the end of the last trading period, the closing price was at $1.49.

With a Sector Outperform rating, Scotiabank initiated coverage on Castle Biosciences Inc CSTL. The price target seems to have been set at $54.00 for Castle Biosciences. In the third quarter, Castle Biosciences showed an EPS of $0.77, compared to $0.44 from the year-ago quarter. At the moment, the stock has a 52-week-high of $48.40 and a 52-week-low of $15.58. Castle Biosciences closed at $23.14 at the end of the last trading period.

With a Sector Outperform rating, Scotiabank initiated coverage on Pacific Biosciences of California Inc PACB. The price target seems to have been set at $12.00 for Pacific Biosciences. Pacific Biosciences earned $0.32 in the third quarter, compared to $0.23 in the year-ago quarter. The current stock performance of Pacific Biosciences shows a 52-week-high of $21.01 and a 52-week-low of $3.85. Moreover, at the end of the last trading period, the closing price was at $8.27.

Scotiabank initiated coverage on Olink Holding AB OLK with a Sector Outperform rating. The price target for Olink Holding is set to $27.00. In the third quarter, Olink Holding showed an EPS of $0.01, compared to $0.05 from the year-ago quarter. The current stock performance of Olink Holding shows a 52-week-high of $26.47 and a 52-week-low of $8.39. Moreover, at the end of the last trading period, the closing price was at $21.26.

DA Davidson initiated coverage on Microsoft Corp MSFT with a Buy rating. The price target for Microsoft is set to $270.00. In the first quarter, Microsoft showed an EPS of $2.35, compared to $2.27 from the year-ago quarter. The current stock performance of Microsoft shows a 52-week-high of $335.20 and a 52-week-low of $213.43. Moreover, at the end of the last trading period, the closing price was at $229.10.

Benchmark initiated coverage on AppLovin Corp APP with a Sell rating. The price target for AppLovin is set to $7.00. AppLovin earned $0.06 in the third quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $95.31 and a 52-week-low of $9.14. AppLovin closed at $10.90 at the end of the last trading period.

EF Hutton initiated coverage on Adaptimmune Therapeutics PLC ADAP with a Buy rating. The price target for Adaptimmune Therapeutics is set to $10.00. In the third quarter, Adaptimmune Therapeutics showed an EPS of $0.24, compared to $0.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.12 and a 52-week-low of $1.01. Adaptimmune Therapeutics closed at $1.78 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on Century Therapeutics Inc IPSC. The price target seems to have been set at $18.00 for Century Therapeutics. For the third quarter, Century Therapeutics had an EPS of $0.53, compared to year-ago quarter EPS of $0.48. The current stock performance of Century Therapeutics shows a 52-week-high of $16.83 and a 52-week-low of $4.69. Moreover, at the end of the last trading period, the closing price was at $4.97.

EF Hutton initiated coverage on Rain Oncology Inc RAIN with a Buy rating. The price target for Rain Oncology is set to $16.00. Rain Oncology earned $0.68 in the third quarter, compared to $0.70 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.03 and a 52-week-low of $2.15. Rain Oncology closed at $8.00 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on BioAtla Inc BCAB. The price target seems to have been set at $25.00 for BioAtla. For the third quarter, BioAtla had an EPS of $0.69, compared to year-ago quarter EPS of $0.68. The current stock performance of BioAtla shows a 52-week-high of $19.29 and a 52-week-low of $2.01. Moreover, at the end of the last trading period, the closing price was at $8.07.

With a Buy rating, EF Hutton initiated coverage on Atara Biotherapeutics Inc ATRA. The price target seems to have been set at $25.00 for Atara Biotherapeutics. Atara Biotherapeutics earned $0.82 in the third quarter, compared to $0.90 in the year-ago quarter. The current stock performance of Atara Biotherapeutics shows a 52-week-high of $16.91 and a 52-week-low of $2.83. Moreover, at the end of the last trading period, the closing price was at $3.35.

EF Hutton initiated coverage on Merus NV MRUS with a Buy rating. The price target for Merus is set to $35.00. Merus earned $0.53 in the third quarter, compared to $0.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.94 and a 52-week-low of $12.03. Merus closed at $15.87 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on Allogene Therapeutics Inc ALLO. The price target seems to have been set at $15.00 for Allogene Therapeutics. For the third quarter, Allogene Therapeutics had an EPS of $0.58, compared to year-ago quarter EPS of $0.57. At the moment, the stock has a 52-week-high of $17.49 and a 52-week-low of $5.55. Allogene Therapeutics closed at $5.80 at the end of the last trading period.

EF Hutton initiated coverage on Bicycle Therapeutics PLC BCYC with a Buy rating. The price target for Bicycle Therapeutics is set to $55.00. In the third quarter, Bicycle Therapeutics showed an EPS of $0.96, compared to $0.59 from the year-ago quarter. At the moment, the stock has a 52-week-high of $59.22 and a 52-week-low of $12.08. Bicycle Therapeutics closed at $30.80 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on G1 Therapeutics Inc GTHX. The price target seems to have been set at $35.00 for G1 Therapeutics. For the third quarter, G1 Therapeutics had an EPS of $0.59, compared to year-ago quarter EPS of $1.00. The stock has a 52-week-high of $17.49 and a 52-week-low of $3.84. At the end of the last trading period, G1 Therapeutics closed at $5.45.

With a Buy rating, EF Hutton initiated coverage on Sinovac Biotech Ltd SVA. The price target seems to have been set at $5.00 for Sinovac Biotech. None

With a Buy rating, EF Hutton initiated coverage on Genenta Science SPA GNTA. The price target seems to have been set at $15.00 for Genenta Science.

With a Buy rating, EF Hutton initiated coverage on Aravive Inc ARAV. The price target seems to have been set at $10.00 for Aravive. For the third quarter, Aravive had an EPS of $0.51, compared to year-ago quarter EPS of $0.53. The current stock performance of Aravive shows a 52-week-high of $2.84 and a 52-week-low of $0.58. Moreover, at the end of the last trading period, the closing price was at $1.53.

EF Hutton initiated coverage on Compugen Ltd CGEN with a Buy rating. The price target for Compugen is set to $13.00. For the third quarter, Compugen had an EPS of $0.14, compared to year-ago quarter EPS of $0.07. The current stock performance of Compugen shows a 52-week-high of $4.64 and a 52-week-low of $0.51. Moreover, at the end of the last trading period, the closing price was at $0.76.

With a Buy rating, EF Hutton initiated coverage on Replimune Group Inc REPL. The price target seems to have been set at $60.00 for Replimune Group. Replimune Group earned $0.79 in the second quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.89 and a 52-week-low of $13.05. Replimune Group closed at $26.25 at the end of the last trading period.

EF Hutton initiated coverage on Fate Therapeutics Inc FATE with a Buy rating. The price target for Fate Therapeutics is set to $16.00. For the third quarter, Fate Therapeutics had an EPS of $0.86, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $59.84 and a 52-week-low of $9.56. Fate Therapeutics closed at $11.12 at the end of the last trading period.

EF Hutton initiated coverage on CRISPR Therapeutics AG CRSP with a Buy rating. The price target for CRISPR Therapeutics is set to $75.00. CRISPR Therapeutics earned $2.24 in the third quarter, compared to $1.67 in the year-ago quarter. The current stock performance of CRISPR Therapeutics shows a 52-week-high of $86.95 and a 52-week-low of $38.94. Moreover, at the end of the last trading period, the closing price was at $45.00.

EF Hutton initiated coverage on TCR2 Therapeutics Inc TCRR with a Hold rating. The price target for TCR2 Therapeutics is set to $2.00. TCR2 Therapeutics earned $0.79 in the third quarter, compared to $0.69 in the year-ago quarter. The current stock performance of TCR2 Therapeutics shows a 52-week-high of $4.71 and a 52-week-low of $0.82. Moreover, at the end of the last trading period, the closing price was at $1.05.

With a Hold rating, EF Hutton initiated coverage on GT Biopharma Inc GTBP. The price target seems to have been set at $2.00 for GT Biopharma. GT Biopharma earned $0.22 in the third quarter, compared to $0.17 in the year-ago quarter. The current stock performance of GT Biopharma shows a 52-week-high of $3.74 and a 52-week-low of $0.88. Moreover, at the end of the last trading period, the closing price was at $1.02.

With a Buy rating, EF Hutton initiated coverage on Atreca Inc BCEL. The price target seems to have been set at $10.00 for Atreca. Atreca earned $0.60 in the third quarter, compared to $0.74 in the year-ago quarter. The stock has a 52-week-high of $5.36 and a 52-week-low of $0.76. At the end of the last trading period, Atreca closed at $1.02.

With a Buy rating, EF Hutton initiated coverage on Apexigen Inc APGN. The price target seems to have been set at $8.00 for Apexigen. At the moment, the stock has a 52-week-high of $31.35 and a 52-week-low of $0.61. Apexigen closed at $0.67 at the end of the last trading period.

See all analyst ratings initiations.